Management of Endocrine Emergencies

  • Miranda M. Broadney
  • Priya Vaidyanathan
  • Bruce L. Klein
  • Joanna S. Cohen


Endocrine emergencies require prompt identification and intervention to prevent morbidity and mortality. This chapter addresses the presentation, diagnosis, initial management, and disposition of patients suffering the following endocrine emergencies: diabetic ketoacidosis, adrenal crisis, hypernatremia secondary to diabetes insipidus, thyroid storm, and hypoglycemia.


Adrenal crisis Diabetes insipidus Diabetic ketoacidosis Hypernatremia Hypoglycemia Thyroid storm Thyrotoxicosis 


  1. 1.
    Sperling MA, Tamborlane WV, Battelino T, Weinzimer SA, Phillip M. Diabetes mellitus. In: Sperling M, editor. Pediatric endocrinology. 4th ed. Philadelphia: Saunders, Inc; 2014. p. 846–900.Google Scholar
  2. 2.
    Wolfsdorf J, Glaser N, Sperling MA, American Diabetes Association. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(5):1150–9. PubMed PMID: 16644656.CrossRefGoogle Scholar
  3. 3.
    Gutierrez JA, Bagatell R, Samson MP, Theodorou AA, Berg RA. Femoral central venous catheter-associated deep venous thrombosis in children with diabetic ketoacidosis. Crit Care Med. 2003;31(1):80–3. PubMed PMID: 12544997.CrossRefGoogle Scholar
  4. 4.
    Worly JM, Fortenberry JD, Hansen I, Chambliss CR, Stockwell J. Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics. 2004;113(1 Pt 1):e57–60. PubMed PMID: 14702496.CrossRefGoogle Scholar
  5. 5.
    Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, et al. ISPAD clinical practice consensus guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15(Suppl 20):154–79. PubMed PMID: 25041509.CrossRefGoogle Scholar
  6. 6.
    Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics. 2004;113(2):e133–40. PubMed PMID: 14754983.CrossRefGoogle Scholar
  7. 7.
    Arieff AI, Kleeman CR. Cerebral edema in diabetic comas. II. Effects of hyperosmolality, hyperglycemia and insulin in diabetic rabbits. J Clin Endocrinol Metab. 1974;38(6):1057–67. PubMed PMID: 4831702.CrossRefGoogle Scholar
  8. 8.
    Duck SC, Wyatt DT. Factors associated with brain herniation in the treatment of diabetic ketoacidosis. J Pediatr. 1988;113(1 Pt 1):10–4. PubMed PMID: 3133455.CrossRefGoogle Scholar
  9. 9.
    Harris GD, Fiordalisi I, Finberg L. Safe management of diabetic ketoacidemia. J Pediatr. 1988;113(1 Pt 1):65–8. PubMed PMID: 3133458.CrossRefGoogle Scholar
  10. 10.
    Harris GD, Fiordalisi I, Harris WL, Mosovich LL, Finberg L. Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: a retrospective and prospective study. J Pediatr. 1990;117(1 Pt 1):22–31. PubMed PMID: 2115081.CrossRefGoogle Scholar
  11. 11.
    Glaser N, Barnett P, McCaslin I, Nelson D, Trainor J, Louie J, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The pediatric emergency medicine collaborative research Committee of the American Academy of pediatrics. N Engl J Med. 2001;344(4):264–9. PubMed PMID: 11172153.CrossRefGoogle Scholar
  12. 12.
    Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146(5):688–92. PubMed PMID: 15870676.CrossRefGoogle Scholar
  13. 13.
    Mahoney CP, Vlcek BW, DelAguila M. Risk factors for developing brain herniation during diabetic ketoacidosis. Pediatr Neurol. 1999;21(4):721–7. PubMed PMID: 10580884.CrossRefGoogle Scholar
  14. 14.
    Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001;85(1):16–22. PubMed PMID: 11420189. Pubmed Central PMCID: 1718828.CrossRefGoogle Scholar
  15. 15.
    Glaser N. New perspectives on the pathogenesis of cerebral edema complicating diabetic ketoacidosis in children. Pediatr Endocrinol Rev: PER. 2006;3(4):379–86. PubMed PMID: 16816806.PubMedGoogle Scholar
  16. 16.
    Durr JA, Hoffman WH, Sklar AH, el Gammal T, Steinhart CM. Correlates of brain edema in uncontrolled IDDM. Diabetes. 1992;41(5):627–32. PubMed PMID: 1568533.CrossRefGoogle Scholar
  17. 17.
    Edge JA, Jakes RW, Roy Y, Hawkins M, Winter D, Ford-Adams ME, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49(9):2002–9. PubMed PMID: 16847700.CrossRefGoogle Scholar
  18. 18.
    Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637. PubMed PMID: 23353941.CrossRefGoogle Scholar
  19. 19.
    Miller WL, Flück CE. Adrenal cortex and its disorders. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia: Saunders, Inc; 2014. p. 508–15.Google Scholar
  20. 20.
    Radovick S, MacGillivray MH. Pediatric endocrinology: a practical clinical guide. 2nd ed. New York: Humana Press; 2013. xv, 624 pp.CrossRefGoogle Scholar
  21. 21.
    Auron M, Raissouni N. Adrenal insufficiency. Pediatr Rev/Am Acad Pediatr. 2015;36(3):92–102; quiz 3, 29. PubMed PMID: 25733761.CrossRefGoogle Scholar
  22. 22.
    Shah SS, CH O, Coffin SE, Yan AC. Addisonian pigmentation of the oral mucosa. Cutis. 2005;76(2):97–9. PubMed PMID: 16209154.PubMedGoogle Scholar
  23. 23.
    Shulman DI, Palmert MR, Kemp SF, Lawson Wilkins D, Therapeutics C. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics. 2007;119(2):e484–94. PubMed PMID: 17242136.CrossRefGoogle Scholar
  24. 24.
    Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015;3(3):216–26. PubMed PMID: 25098712.CrossRefGoogle Scholar
  25. 25.
    Spiegel RJ, Vigersky RA, Oliff AI, Echelberger CK, Bruton J, Poplack DG. Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979;1(8117):630–3. PubMed PMID: 85870.CrossRefGoogle Scholar
  26. 26.
    Chrousos G, Pavlaki AN, Magiakou MA. Glucocorticoid therapy and adrenal suppression. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, et al., editors. Endotext. South Dartmouth:, Inc.; 2000.Google Scholar
  27. 27.
    Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med. 2009;360(22):2328–39. PubMed PMID: 19474430.CrossRefGoogle Scholar
  28. 28.
    Grinspoon SK, Biller BM. Clinical review 62: laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994;79(4):923–31. PubMed PMID: 7962298.PubMedGoogle Scholar
  29. 29.
    de Caen AR, Maconochie IK, Aickin R, Atkins DL, Biarent D, Guerguerian AM, et al. Part 6: pediatric basic life support and pediatric advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations (reprint). Pediatrics. 2015;136(Suppl 2):S88–119. PubMed PMID: 26471382.CrossRefGoogle Scholar
  30. 30.
    Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW, et al. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res. 2002;58(4):188–95. PubMed PMID: 12324718.PubMedGoogle Scholar
  31. 31.
    Hegenbarth MA. American Academy of Pediatrics Committee on D. Preparing for pediatric emergencies: drugs to consider. Pediatrics. 2008;121(2):433–43. PubMed PMID: 18245435.CrossRefGoogle Scholar
  32. 32.
    Lui K, Thungappa U, Nair A, John E. Treatment with hypertonic dextrose and insulin in severe hyperkalaemia of immature infants. Acta Paediatr. 1992;81(3):213–6. PubMed PMID: 1511193.CrossRefGoogle Scholar
  33. 33.
    Majzoub JA, Muglia LJ, Srivatsa A. Disorders of the posterior pituitary. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia: Saunders, Inc; 2014. p. 405–43.Google Scholar
  34. 34.
    Hirasawa A, Hashimoto K, Tsujimoto G. Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats. Eur J Pharmacol. 1994;267(1):71–5. PubMed PMID: 8206132.CrossRefGoogle Scholar
  35. 35.
    Mishra G, Chandrashekhar SR. Management of diabetes insipidus in children. Indian J Endocrinol Metab. 2011;15(Suppl 3):S180–7. PubMed PMID: 22029022. Pubmed Central PMCID: 3183526.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Saborio P, Tipton GA, Chan JC. Diabetes insipidus. Pediatr Rev/Am Acad Pediatr. 2000;21(4):122–9; quiz 9. PubMed PMID: 10756175.CrossRefGoogle Scholar
  37. 37.
    Di Iorgi N, Allegri AE, Napoli F, Calcagno A, Calandra E, Fratangeli N, et al. Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J Clin Endocrinol Metab. 2014;99(4):1264–72. PubMed PMID: 24276447.CrossRefGoogle Scholar
  38. 38.
    Werny D, Elfers C, Perez FA, Pihoker C, Roth CL. Pediatric central diabetes insipidus: brain malformations are common and few patients have idiopathic disease. J Clin Endocrinol Metab. 2015;100(8):3074–80. PubMed PMID: 26030323.CrossRefGoogle Scholar
  39. 39.
    Marchand I, Barkaoui MA, Garel C, Polak M, Donadieu J, Writing C. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents. J Clin Endocrinol Metab. 2011;96(9):E1352–60. PubMed PMID: 21752883.CrossRefGoogle Scholar
  40. 40.
    Masera N, Grant DB, Stanhope R, Preece MA. Diabetes insipidus with impaired osmotic regulation in septo-optic dysplasia and agenesis of the corpus callosum. Arch Dis Child. 1994;70(1):51–3. PubMed PMID: 8110009. Pubmed Central PMCID: 1029683.CrossRefGoogle Scholar
  41. 41.
    Secco A, Allegri AE, di Iorgi N, Napoli F, Calcagno A, Bertelli E, et al. Posterior pituitary (PP) evaluation in patients with anterior pituitary defect associated with ectopic PP and septo-optic dysplasia. Eur J Endocrinol/Eur Fed Endocr Societ. 2011;165(3):411–20. PubMed PMID: 21750044.CrossRefGoogle Scholar
  42. 42.
    Repaske DR, Medlej R, Gultekin EK, Krishnamani MR, Halaby G, Findling JW, et al. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-->Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor. J Clin Endocrinol Metab. 1997;82(1):51–6. PubMed PMID: 8989232.PubMedGoogle Scholar
  43. 43.
    Bichet DG, Oksche A, Rosenthal W. Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol: JASN. 1997;8(12):1951–8. PubMed PMID: 9402099.PubMedGoogle Scholar
  44. 44.
    Saifan C, Nasr R, Mehta S, Sharma Acharya P, Perrera I, Faddoul G, et al. Diabetes insipidus: a challenging diagnosis with new drug therapies. ISRN Nephrol. 2013;2013:797620. PubMed PMID: 24977135. Pubmed Central PMCID: 4045430.CrossRefGoogle Scholar
  45. 45.
    Di Iorgi N, Morana G, Napoli F, Allegri AE, Rossi A, Maghnie M. Management of diabetes insipidus and adipsia in the child. Best Pract Res Clin Endocrinol Metab. 2015;29(3):415–36. PubMed PMID: 26051300.CrossRefGoogle Scholar
  46. 46.
    Fenske W, Allolio B. Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab. 2012;97(10):3426–37. PubMed PMID: 22855338.CrossRefGoogle Scholar
  47. 47.
    Souza AC, Zatz R, de Oliveira RB, Santinho MA, Ribalta M, Romao JE Jr, et al. Is urinary density an adequate predictor of urinary osmolality? BMC Nephrol. 2015;16:46. PubMed PMID: 25884505. Pubmed Central PMCID: 4404565.CrossRefGoogle Scholar
  48. 48.
    Thomas WC Jr. Diabetes insipidus. J Clin Endocrinol Metab. 1957;17(4):565–82. PubMed PMID: 13406019.CrossRefGoogle Scholar
  49. 49.
    Jain A. Body fluid composition. Pediatr Rev/Am Acad Pediatr. 2015;36(4):141–50; quiz 51-2. PubMed PMID: 25834218.CrossRefGoogle Scholar
  50. 50.
    Bolat F, Oflaz MB, Guven AS, Ozdemir G, Alaygut D, Dogan MT, et al. What is the safe approach for neonatal hypernatremic dehydration? A retrospective study from a neonatal intensive care unit. Pediatr Emerg Care. 2013;29(7):808–13. PubMed PMID: 23823259.CrossRefGoogle Scholar
  51. 51.
    Fang C, Mao J, Dai Y, Xia Y, Fu H, Chen Y, et al. Fluid management of hypernatraemic dehydration to prevent cerebral oedema: a retrospective case control study of 97 children in China. J Paediatr Child Health. 2010;46(6):301–3. PubMed PMID: 20412412.CrossRefGoogle Scholar
  52. 52.
    Kahn A, Brachet E, Blum D. Controlled fall in natremia and risk of seizures in hypertonic dehydration. Intensive Care Med. 1979;5(1):27–31. PubMed PMID: 35558.CrossRefGoogle Scholar
  53. 53.
    Akamizu T, Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid : Official Journal of the American Thyroid Association. 2012;22(7):661–79. PubMed PMID: 22690898. Pubmed Central PMCID: 3387770.CrossRefGoogle Scholar
  54. 54.
    Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223–43. PubMed PMID: 9281381.CrossRefGoogle Scholar
  55. 55.
    Srinivasan S, Misra M. Hyperthyroidism in children. Pediatr Rev/Am Acad Pediatr. 2015;36(6):239–48. PubMed PMID: 26034254.CrossRefGoogle Scholar
  56. 56.
    Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin N Am. 1993;22(2):263–77. PubMed PMID: 8325286.Google Scholar
  57. 57.
    Vliet GV, Deladoëy J. Disorders of the thyroid in the newborn and infant. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadephia: Saunders, Inc; 2014. p. 186–208.Google Scholar
  58. 58.
    Kwon KT, Tsai VW. Metabolic emergencies. Emerg Med Clin North Am. 2007;25(4):1041–60, vi. PubMed PMID: 17950135.CrossRefGoogle Scholar
  59. 59.
    Sarlis NJ, Gourgiotis L. Thyroid emergencies. Rev Endocr Metab Disord. 2003;4(2):129–36. PubMed PMID: 12766540.CrossRefGoogle Scholar
  60. 60.
    Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2011;17(3):456–520. PubMed PMID: 21700562.CrossRefGoogle Scholar
  61. 61.
    Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin N Am. 2006;35(4):663–86, vii. PubMed PMID: 17127140.CrossRefGoogle Scholar
  62. 62.
    Rivkees SA. Pediatric Graves' disease: controversies in management. Horm Res Paediatr. 2010;74(5):305–11. PubMed PMID: 20924158.CrossRefGoogle Scholar
  63. 63.
    Pershad J, Monroe K, Atchison J. Childhood hypoglycemia in an urban emergency department: epidemiology and a diagnostic approach to the problem. Pediatr Emerg Care. 1998;14(4):268–71. PubMed PMID: 9733249.CrossRefGoogle Scholar
  64. 64.
    Losek JD. Hypoglycemia and the ABC'S (sugar) of pediatric resuscitation. Ann Emerg Med. 2000;35(1):43–6. PubMed PMID: 10613939.CrossRefGoogle Scholar
  65. 65.
    Cornblath M, Reisner SH. Blood glucose in the neonate and its clinical significance. N Engl J Med. 1965;273(7):378–81. PubMed PMID: 21417085.CrossRefGoogle Scholar
  66. 66.
    Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015;167(2):238–45. PubMed PMID: 25957977.CrossRefGoogle Scholar
  67. 67.
    Daly LP, Osterhoudt KC, Weinzimer SA. Presenting features of idiopathic ketotic hypoglycemia. J Emerg Med. 2003;25(1):39–43. PubMed PMID: 12865107.CrossRefGoogle Scholar
  68. 68.
    LaFranchi S. Hypoglycemia of infancy and childhood. Pediatr Clin N Am. 1987;34(4):961–82. PubMed PMID: 3302901.CrossRefGoogle Scholar
  69. 69.
    Langdon DR, Stanley CA, Sperling MA. Hypoglycemia in the todller and child. In: Sperling M, editor. Pediatric endocrinology. 4th ed. Philadephia, PA: Saunders, Inc; 2014. p. 920–55.Google Scholar
  70. 70.
    Temple AR. Pathophysiology of aspirin overdosage toxicity, with implications for management. Pediatrics. 1978;62(5 Pt 2 Suppl):873–6. PubMed PMID: 364398.PubMedGoogle Scholar
  71. 71.
    Lteif AN, Schwenk WF. Hypoglycemia in infants and children. Endocrinol Metab Clin N Am. 1999;28(3):619–46, vii. PubMed PMID: 10500934.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Miranda M. Broadney
    • 1
  • Priya Vaidyanathan
    • 2
  • Bruce L. Klein
    • 3
  • Joanna S. Cohen
    • 4
  1. 1.Eunice Kennedy Shriver National Institute of Child Health and Human Development, Section on Growth and ObesityNational Institutes of HealthBethesdaUSA
  2. 2.EndocrinologyChildren’s National Medical CenterWashingtonUSA
  3. 3.Pediatric Emergency Medicine, Pediatric Transport, Department of PediatricsThe Johns Hopkins HospitalBaltimoreUSA
  4. 4.Pediatrics and Emergency MedicineChildren’s National Health CenterWashingtonUSA

Personalised recommendations